Apellis Pharmaceuticals, Inc. ($APLS)
Filing Information
| Accession Number | 0001492422-26-000017 |
|---|---|
| Form Type | 4 |
| Filing Date | Jan 9, 2026 |
| Document Date | Jan 7, 2026 |
| Document | View SEC Filing |
Transactions
2
Total Shares
1,776
Total Value
$13,275.60
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
General Counsel | Common Stock | โ | Jan 7, 2026 | Exercise/Conversion | 888 | $14.95 | $13,275.60 | 104,618 | Direct | โ | View Details | |
General Counsel | Stock Option (Right to Buy) | Derivative | Jan 7, 2026 | Exercise/Conversion | 888 | $0.00 | $0.00 | 14,000 | Direct | โ | View Details |